AstraZeneca to buy pharmaceutical firm Alexion
AstraZeneca to buy pharmaceu...
Subscribe to Newsletter

AstraZeneca to buy pharmaceutical firm Alexion

13 December 2020
3136
1 min.
5
AstraZeneca to buy pharmaceutical firm Alexion

Treating rare diseases

Alexion develops drugs for rare diseases and also creates monoclonal antibodies. They have been attracting more attention recently as some have started using them to treat COVID-19

Anglo-Swedish pharmaceutical company AstraZeneca will buy US pharmaceutical firm Alexion Pharmaceuticals for $39bn, according to a statement on AstraZeneca's website.

The deal has been approved by the management of both companies. It now needs regulatory approval and shareholder approval.

The deal is scheduled to close in the third quarter of 2021. As a result, Alexion shareholders will receive approximately 15% of the combined company.

Alexion develops drugs to treat complex and rare diseases in the fields of nephrology, neurology, metabolism, oncology and haematology. In particular, it creates monoclonal antibodies that are injected into patients to target the body's response to foreign antigens.

Monoclonal antibodies have attracted more attention recently as two such drugs, manufactured by pharmaceutical companies Eli Lilly Company and Regeneron Pharmaceuticals, have been approved for use in the US for the treatment of coronavirus, Bloomberg reports.

Companies5 in the news

Alexion
1 place
AstraZeneca
2 place
Regeneron
3 place
Bloomberg L.P.
5 place
Section:
Rating companies
Instagram
18 Mention
Netflix
14 Mention
X (Twitter)
12 Mention
TikTok
8 Mention
Tesla
8 Mention
White House
7 Mention
JP Morgan Chase
7 Mention
Us Weekly
7 Mention

NEW YORK NEWS

News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova

Development Director
Population
8174048323
Died this year
56313889
Born this year
138542134